FDA clears CAD between Fischer Imaging and R2 Technology

The FDA has given the go-ahead to Fischer Imaging Corp. and R2 Technology Inc. to integrate their respective technologies.

 The ruling allows Fischer Imaging to integrate its SenoScan digital mammography system with R2's computer-aided detection (CAD) technology. In addition, R2 Technology's ImageChecker DM analog system -- which received FDA clearance in September -- also will support CAD analysis of digital images acquired on the SenoScan system.

 The ImageChecker DM System will be distributed directly by Fischer and R2.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup